On the International Scene

December 1, 1999 Advisory


Congratulations to Jim Farrington, who has been in Sweden since late 1997, and his team, for successfully shepherding the sale of Pharmacia & Upjohn, Inc.'s intravenous drug business to Germany's Fresenius AG through 14 separate pre-merger filings in Europe and North America. Wiggin & Dana was lead counsel in this $500 million divestment which involved assets and businesses in some 75 countries.

UK competition law was recently changed by The Competition Act 1998, to make it conform to antitrust law elsewhere in the EU. The Act replaces the Restrictive Trade Practices Act 1976, and will become effective on March 1, 2000.